91麻豆天美直播

Skip to main content

Researchers Uncover Insights into How Moles Change into Melanoma

Read Time: 4 minutes

Robert Judson-Torres, PhD
Robert Judson-Torres, PhD

Moles and melanomas are both skin tumors that come from the same cell called melanocytes. The difference is that moles are usually harmless, while melanomas are cancerous and often deadly without treatment. published today in eLife Magazine, , Huntsman Cancer Institute researcher and (the U) assistant professor of dermatology and oncological sciences, explains how common moles and melanomas form and why moles can change into melanoma.

Melanocytes are cells that give color to the skin to protect it from the sun鈥檚 rays. Specific changes to the DNA sequence of melanocytes, called BRAF gene mutations, are found in over 75% of moles. The same change is also found in 50% of melanomas and is common in cancers like colon and lung. It was thought that when melanocytes only have the BRAFV600E mutation the cell stops dividing, resulting in a mole. When melanocytes have other mutations with BRAFV600E, they divide uncontrollably, turning into melanoma. This model is called 鈥渙ncogene-induced senescence.鈥

鈥淎 number of studies have challenged this model in recent years,鈥 says Judson-Torres. 鈥淭hese studies have provided excellent data to suggest that the oncogene-induced senescence model does not explain mole formation but what they have all lacked is an alternative explanation鈥攚hich has remained elusive.鈥

With help from collaborators across Huntsman Cancer Institute and the University of California San Francisco, the study team took moles and melanomas donated by patients and used transcriptomic profiling and digital holographic cytometry. Transcriptomic profiling lets researchers determine molecular differences between moles and melanomas. Digital holographic cytometry helps researchers track changes in human cells.

Group photo of Doug Grossman, MD, PhD, Robert Judson-Torres, PhD, David Lum, PhD, Matthew VanBrocklin, PhD, Sheri Holmen, PhD
Doug Grossman, MD, PhD | Robert Judson-Torres, PhD | David Lum, PhD | Matthew VanBrocklin, PhD | Sheri Holmen, PhD

鈥淲e discovered a new molecular mechanism that explains how moles form, how melanomas form, and why moles sometimes become melanomas,鈥 says Judson-Torres.

The study shows melanocytes that turn into melanoma do not need to have additional mutations but are actually affected by environmental signaling, when cells receive signals from the environment in the skin around them that give them direction. Melanocytes express genes in different environments, telling them to either divide uncontrollably or stop dividing altogether.

鈥淥rigins of melanoma being dependent on environmental signals gives a new outlook in prevention and treatment,鈥 says Judson-Torres. 鈥淚t also plays a role in trying to combat melanoma by preventing and targeting genetic mutations. We might also be able to combat melanoma by changing the environment.鈥

These findings create a foundation for researching potential melanoma biomarkers, allowing doctors to detect cancerous changes in the blood at earlier stages. The researchers are also interested in using these data to better understand potential topical agents to reduce the risk of melanoma, delay development, or stop recurrence, and to detect melanoma early.

The study was funded by National Institutes of Health/National Cancer Institute including P30 CA042014, 5 For The Fight, and Huntsman Cancer Foundation. Judson-Torres recognizes critical contributions by other Huntsman Cancer Institute scientists, including ; ; ; David Lum, PhD; Doug Grossman, MD, PhD; and University of California San Francisco scientists Andrew McNeal, PhD; Maria Wei, MD, PhD; and Ursula Lang, MD, PhD.

Media Contact

Heather Simonsen
Public Affairs Senior Manager
Huntsman Cancer Institute
801 581-3194
public.affairs@hci.utah.edu

About Huntsman Cancer Institute at the University of Utah

Huntsman Cancer Institute at the is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the most advanced cancer healing and prevention through scientific breakthroughs and cutting-edge technology to advance cancer treatments of the future beyond the standard of care today. We have more than 300 open clinical trials and 250 research teams studying cancer. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient鈥檚 unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.

Resources for Media

Cancer touches all of us.